Original Research
Published on 12 Dec 2023
Deciphering the Hypoxia-immune interface in esophageal squamous carcinoma: a prognostic network model
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1296814
- 1,056 views
Type at least 3 characters
1,278 articles
Articles
Systematic Review
Published on 07 Dec 2023
Efficacy and safety of anti-CD38 monoclonal antibodies in patients with relapsed/refractory multiple myeloma: a systematic review and meta-analysis with trial sequential analysis of randomized controlled trials
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1240318
- 2,618 views
- 1 citation
Original Research
Published on 07 Dec 2023
Interferon gamma immunoPET imaging to evaluate response to immune checkpoint inhibitors
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1285117
- 1,733 views
- 1 citation
Review
Published on 06 Dec 2023
Immunogenic chemotherapy: great potential for improving response rates
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1308681
- 1,467 views
- 3 citations
Review
Published on 05 Dec 2023
Role of gonadally synthesized steroid hormones in the colorectal cancer microenvironment
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1323826
- 987 views
Mini Review
Published on 04 Dec 2023
Circadian lifestyle determinants of immune checkpoint inhibitor efficacy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1284089
- 2,101 views
Mini Review
Published on 01 Dec 2023
A narrative review of antibody–drug conjugates in EGFR-mutated non-small cell lung cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1252652
- 7,842 views
- 3 citations
Review
Published on 28 Nov 2023
The multiple roles of C-type lectin receptors in cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1301473
- 1,489 views
- 2 citations
Review
Published on 28 Nov 2023
Current tests for diagnosis of hepatitis B virus infection and immune responses of HBV-related HCC
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1185142
- 1,807 views
Original Research
Published on 28 Nov 2023
Immune checkpoint inhibitor-induced colitis with endoscopic evaluation in Chinese cancer patients: a single-centre retrospective study
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1285478
- 913 views
Case Report
Published on 28 Nov 2023
A case report and literature review on reactive cutaneous capillary endothelial proliferation induced by camrelizumab in a nasopharyngeal carcinoma patient
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1280208
- 834 views
- 2 citations
Review
Published on 22 Nov 2023
Gut–lung axis: role of the gut microbiota in non-small cell lung cancer immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1257515
- 2,283 views
- 3 citations
Original Research
Published on 22 Nov 2023
Immune changes in hilar tumor draining lymph nodes following node sparing neoadjuvant chemoradiotherapy of localized cN0 non-small cell lung cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1269166
- 1,588 views
Mini Review
Published on 22 Nov 2023
Cannabinoids and the endocannabinoid system in immunotherapy: helpful or harmful?
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1296906
- 3,046 views
- 2 citations
Original Research
Published on 20 Nov 2023
Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell infiltration and modulation of tumour microenvironment in mesothelioma mouse model
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1259314
- 2,390 views
- 2 citations
Review
Published on 16 Nov 2023
Similarities and divergences in the metabolism of immune cells in cancer and helminthic infections
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1251355
- 1,492 views